Wikidata:Database reports/Constraint violations/P780
Constraint violations report for symptoms and signs (Discussion, uses, items, changes, related properties): possible symptoms or signs of a medical condition
Data time stamp: (UTC) — Items processed: 1,842
The report is generated based on the settings on Property:P780#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
Data time stamp: (UTC) — Items processed: 1,842
The report is generated based on the settings on Property:P780#P2302.
Updates overwrite this page. Some may already be fixed since the last update: check RecentChangesLinked.
When incremental dumps and the bot work as planned, items fixed before 07:00 UTC disappear in the next update. The report is not updated if only the item count changes.
The report can include false positives. There is no need to "fix" them.
"Value type clinical sign (Q1441305), symptom (Q169872), health problem (Q2057971)" violations edit
Violations count: 178
- chronic thyroiditis (Q11094): anti-thyroid autoantibodies (Q1943709): antibody (Q79460), autoantibody (Q785022)
- tuberculosis (Q12204): fatigue (Q15729017): physiological phenomenon (Q66615932), mental state (Q54989186), physiological condition (Q7189713)
- smallpox (Q12214): scar (Q206060): tissue (Q40397)
- frontotemporal dementia (Q18592): change (Q1150070): philosophical concept (Q33104279), occurrent (Q67518978)
- leprosy (Q36956): mutilation (Q767568): violence (Q124490)
- rabies (Q39222): increase (Q9073584): change (Q1150070), occurrence (Q1190554)
- rabies (Q39222): increase (Q9073584): change (Q1150070), occurrence (Q1190554)
- chickenpox (Q44727): vesicle (Q189206): cellular component (Q5058355), membrane-bounded organelle (Q21423046)
- yaws (Q76973): scar (Q206060): tissue (Q40397)
- typhoid fever (Q83319): confusion of consciousness (Q65202123):
- gonorrhea (Q101896): excretion (Q185557): biological process (Q2996394), system process (Q22299483), expulsion (Q779939)
- antisocial personality disorder (Q118418): anti-social behaviour (Q734611): human behavior (Q3769299), social issue (Q1920219)
- antisocial personality disorder (Q118418): fraud (Q28813): elements of an offence (Q20820018), cheating (Q19), deception (Q170028), crime (Q83267)
- antisocial personality disorder (Q118418): violence (Q124490): matter (Q26256810), aggression (Q191797), activity (Q1914636)
- carbon monoxide poisoning (Q125367): ST depression (Q3965303): medical finding (Q639907), finding of ST segment (Q44478563)
- cataract (Q127724): glare (Q72759): phenomenon (Q483247), visible spectrum (Q76299)
- diphtheria (Q134649): pseudomembrane (Q1495301): exudate (Q1139400)
- brucellosis (Q156050): undulant fever (Q29644037): fever type (Q24869936)
- persistent genital arousal disorder (Q176671): sexual arousal (Q215127): arousal (Q379784)
- post-traumatic stress disorder (Q202387): nightmare (Q192692): dream (Q36348)
- post-traumatic stress disorder (Q202387): heart rate variability (Q933954): physiological condition (Q7189713)
- borderline personality disorder (Q208166): emotional self-regulation (Q2267800): pattern of behavior (Q2515887), self-control (Q1405524)
- borderline personality disorder (Q208166): anger (Q79871): negative emotion (Q60539481), basic emotion (Q16748867), seven deadly sins (Q166502), emotion (Q9415)
- chronic fatigue syndrome (Q209733): lymph node (Q170758): class of anatomical entity (Q112826905), organ component (Q62122079), lymphoid organ (Q66502804), particular anatomical entity (Q112826975)
- giardiasis (Q326071): fatigue (Q15729017): physiological phenomenon (Q66615932), mental state (Q54989186), physiological condition (Q7189713)
- Rift Valley fever (Q326638): confusion of consciousness (Q65202123):
- thallium poisoning (Q374832): xeroderma (Q1929023): dryness (Q5309747)
- thallium poisoning (Q374832): heart damage (Q21128925):
- amentia (Q462833): perplexity (Q58184039): emotional process (Q4531715)
- complex post-traumatic stress disorder (Q477502): nightmare (Q192692): dream (Q36348)
- complex post-traumatic stress disorder (Q477502): fight-or-flight response (Q1640582): concept (Q151885), startle response (Q430986)
- schizoid personality disorder (Q498237): social isolation (Q1778765): social phenomenon (Q602884), solitude (Q6010868), risk factor (Q1475848), human behavior (Q3769299)
- tetany (Q511818): tetanic contraction (Q1632123): muscle contraction (Q127006)
- anticholinergic toxidrome (Q574975): xeroderma (Q1929023): dryness (Q5309747)
- hepatic encephalopathy (Q642548): euphoria (Q203994): positive emotion (Q60539479), mood (Q331769), biological process (Q2996394), condition (Q813912)
- death rattle (Q663998): sound (Q11461): acoustic wave (Q3882459), longitudinal wave (Q626707)
- bejel (Q682798): scar (Q206060): tissue (Q40397)
- Rocky Mountain spotted fever (Q744387): prodrome (Q1140331): disease stage (Q10960555)
- Murray Valley encephalitis (Q782898): prodrome (Q1140331): disease stage (Q10960555)
- Murray Valley encephalitis (Q782898): confusion of consciousness (Q65202123):
- fatal familial insomnia (Q862872): human ageing (Q332154): biological process (Q2996394), failure mode (Q100151658), developmental process (Q2843407), degradation (Q94643648), senescence (Q2070979)
- postpartum depression (Q935129): crying (Q152247): mood (Q331769), facial expression (Q327968)
- acrodermatitis enteropathica (Q937818): cerebral cortical atrophy (Q46978740):
- acrodermatitis enteropathica (Q937818): xeroderma (Q1929023): dryness (Q5309747)
- gastroparesis (Q943897): satiety (Q1562684): physiology (Q521), contentment (Q352126), satiation (Q66615326)
- amebiasis (Q949694): Colonic ulcerations may predict steroid-refractory course in patients with ipilimumab-mediated enterocolitis (Q37714359): scholarly article (Q13442814)
- rickettsialpox (Q1048101): vesicle (Q189206): cellular component (Q5058355), membrane-bounded organelle (Q21423046)
- cowpox (Q1066011): vesicle (Q189206): cellular component (Q5058355), membrane-bounded organelle (Q21423046)
- microcytosis (Q1091552): microcyte (Q6839437): cell type (Q189118), red blood cell (Q37187), abnormal cell (Q106161446)
- ketosis (Q1123139): ketonemia (Q23021271):
- pica (Q1134891): eating (Q213449): eating behavior (Q14820887), ingestion (Q1663054), activity (Q1914636)
- hepatocellular carcinoma (Q1148337): sweat (Q3503092): class of anatomical entity (Q112826905), excrement (Q1383944), secretion (Q12334861), excretion (Q185557), particular anatomical entity (Q112826975)
- leukocyte-adhesion deficiency syndrome (Q1154422): delayed separation of umbilical cord (Q18966290):
- epidemic typhus (Q1290616): euphoria (Q203994): positive emotion (Q60539479), mood (Q331769), biological process (Q2996394), condition (Q813912)
- hypertrophic cardiomyopathy (Q1364270): fatigue (Q15729017): physiological phenomenon (Q66615932), mental state (Q54989186), physiological condition (Q7189713)
- copropraxia (Q1428295): obscenity (Q31110): provocation (Q257931), rudeness (Q4122037)
- freemartinism (Q1453590): androgyny (Q207959): gender expression (Q15404978), identity (Q844569), sexual diversity (Q5110203)
- common variable immunodeficiency (Q1472818): malignancy (Q1483951): disease attributes (Q54932064), medical attribute (Q44476427), health risk (Q87075524)
- hitting the wall (Q1567709): fatigue (Q15729017): physiological phenomenon (Q66615932), mental state (Q54989186), physiological condition (Q7189713)
- Tanganyika laughter epidemic (Q1582992): laughter (Q170579): facial expression (Q327968), smiling or laughing (Q124957980), animal vocalization (Q97234227)
- popliteal pterygium syndrome (Q1587881): pterygium (Q17142318):
- hemoglobinopathy (Q1642147): abnormal hemoglobins (Q77836916): hemoglobin (Q43041)
- Attention deficit hyperactivity disorder predominantly inattentive (Q1993146): daydream (Q6028924): mental process (Q781413), fantasy (Q1356411)
- thelaziasis (Q2090711): sense (Q173253): psychology term (Q96634632), aptitude (Q1347367)
- fasciolopsiasis (Q2140729): hunger (Q165947): physical fitness (Q309252), sensation (Q3955369), cause of death (Q1931388)
- cutaneous leishmaniasis (Q2590966): scar (Q206060): tissue (Q40397)
- human coprophagia (Q2996866): coprophagia (Q320011): feeding behavior (Q14819856)
- myostatin-related muscle hypertrophy (Q3144217): muscle hypertrophy (Q1955391): biological process (Q2996394), muscle system process (Q21119139)
- toluene toxicity (Q3153686): euphoria (Q203994): positive emotion (Q60539479), mood (Q331769), biological process (Q2996394), condition (Q813912)
- postterm pregnancy (Q3399863): reduction (Q47496130): change (Q1150070)
- drop attack (Q3629075): falling (Q333495): accident (Q171558)
- hereditary stomatocytosis (Q3973817): stomatocyte (Q3973815):
- Brugia malayi filariasis (Q4097126): cellulite (Q242510): anatomical variation (Q4752279), gynoid fat distribution (Q25091544)
- Nanophyetiasis (Q4312883): fatigue (Q15729017): physiological phenomenon (Q66615932), mental state (Q54989186), physiological condition (Q7189713)
- psychological dependence (Q4420150): craving (Q391682): desire (Q775842)
- psychological dependence (Q4420150): psychological stress (Q3500368): negative emotion (Q60539481), mental state (Q3968640), risk factor (Q1475848), stress (Q123414)
- acroosteolysis (Q4676384): osteolysis (Q2035084): bone resorption (Q4941581)
- GRACILE syndrome (Q5514398): decreased transferrin saturation (Q46981118):
- GRACILE syndrome (Q5514398): renal Fanconi syndrome (Q46981523):
- myocardial infarction with ST segment elevation (Q5915679): ST elevation (Q7394928): medical finding (Q639907), finding of ST segment (Q44478563)
- progeroid syndrome (Q6139748): senescence (Q2070979): physiological condition (Q7189713), degradation (Q94643648), risk factor (Q1475848)
- dysgeusia (Q6402731): sourness (Q2795949): basic taste (Q4338148), flavoring (Q4173974)
- nicotine poisoning (Q7030575): vasoconstriction (Q1067506): biological process (Q2996394), blood vessel diameter maintenance (Q27948870)
- Powassan encephalitis (Q7235947): confusion of consciousness (Q65202123):
- strychnine poisoning (Q7625508): tetanic contraction (Q1632123): muscle contraction (Q127006)
- strychnine poisoning (Q7625508): stiffness (Q569057): mechanical property (Q5725005), physical quantity (Q107715)
- spherocytosis (Q11181178): spherocyte (Q2309690): poikilocyte (Q108554764)
- premature rupture of membranes (Q11703370): rupture of membranes (Q176918): physiological process (Q30892994)
- Nightmare disorder (Q12859193): nightmare (Q192692): dream (Q36348)
- multiple pterygium syndrome (Q16889762): pterygium (Q17142318):
- firefly shrimp (Q18456733): bioluminescence (Q179924): biological process (Q2996394), color in nature (Q105096490), cell metabolism (Q13416689), luminescence (Q184240)
- Rocio virus encephalitis (Q18924547): prodrome (Q1140331): disease stage (Q10960555)
- manic episode (Q18966903): exaltation (Q1276947): mood (Q331769), positive emotion (Q60539479)
- fusion with defective stereopsis (Q18967299): Q25387291:
- aphantasia (Q20707611): non-existence (Q3877969): quality (Q1207505), property (Q937228)
- acetic acid exposure (Q21167527): corrosion (Q137056): chemical phenomenon (Q3382117), wear (Q617224), material degradation (Q112616165)
- acetone exposure (Q21167550): xeroderma (Q1929023): dryness (Q5309747)
- allyl glycidyl ether exposure (Q21167694): xeroderma (Q1929023): dryness (Q5309747)
- amyl acetate exposure (Q21167792): xeroderma (Q1929023): dryness (Q5309747)
- benzene exposure (Q21167939): euphoria (Q203994): positive emotion (Q60539479), mood (Q331769), biological process (Q2996394), condition (Q813912)
- phenacyl chloride exposure (Q21173555): panic (Q208450): negative emotion (Q60539481)
- phenacyl chloride exposure (Q21173555): denudation (Q745430): geology (Q1069), exogenetic process (Q11430323), geological process (Q10928429)
- chloroform exposure (Q21173565): anaesthesia (Q131130): altered state of consciousness (Q852859)
- 2-chlorotoluene exposure (Q21173573): anaesthesia (Q131130): altered state of consciousness (Q852859)
- cyclopentane exposure (Q21174128): euphoria (Q203994): positive emotion (Q60539479), mood (Q331769), biological process (Q2996394), condition (Q813912)
- endrin exposure (Q21174249): aggression (Q191797): action (Q4026292)
- enflurane exposure (Q21174250): anaesthesia (Q131130): altered state of consciousness (Q852859)
- ethylene glycol exposure (Q21174292): euphoria (Q203994): positive emotion (Q60539479), mood (Q331769), biological process (Q2996394), condition (Q813912)
- ferbam exposure (Q21174317): respiratory tract (Q13400765): anatomical structure (Q4936952), class of anatomical entity (Q112826905), particular anatomical entity (Q112826975)
- fluoroxene exposure (Q21174325): anaesthesia (Q131130): altered state of consciousness (Q852859)
- furfuryl alcohol exposure (Q21174338): diuresis (Q584691): biological process (Q2996394)
- halothane exposure (Q21174630): anaesthesia (Q131130): altered state of consciousness (Q852859)
- Isobutyl acetate exposure (Q21174779): anaesthesia (Q131130): altered state of consciousness (Q852859)
- methoxyflurane exposure (Q21174889): anaesthesia (Q131130): altered state of consciousness (Q852859)
- methylacetylene exposure (Q21174892): anaesthesia (Q131130): altered state of consciousness (Q852859)
- MAPP gas exposure (Q21174893): anaesthesia (Q131130): altered state of consciousness (Q852859)
- dimethoxymethane exposure (Q21174896): anaesthesia (Q131130): altered state of consciousness (Q852859)
- methyl ethyl ketone peroxide exposure (Q21174916): scar (Q206060): tissue (Q40397)
- phenyl glycidyl ether exposure (Q21175045): upper respiratory tract (Q3276159): organism subdivision type (Q103843042), class of anatomical entity (Q112826905), subdivision of respiratory system (Q66536013), particular anatomical entity (Q112826975)
- portland cement exposure (Q21175068): spitting (Q740540): excretion (Q185557)
- sodium cyanide exposure (Q21175308): corrosion (Q137056): chemical phenomenon (Q3382117), wear (Q617224), material degradation (Q112616165)
- tetramethyllead exposure (Q21175351): nightmare (Q192692): dream (Q36348)
- abrin exposure (Q21281647): death (Q4): end (Q12769393), concept (Q151885), property (Q937228), occurrence (Q1190554)
- colchicine toxicity (Q21402492): death (Q4): end (Q12769393), concept (Q151885), property (Q937228), occurrence (Q1190554)
- lewisite exposure (Q21504975): scar (Q206060): tissue (Q40397)
- exposure to mustard–lewisite mixture (Q21505396): immunosuppression (Q1455316): immunotherapy (Q1427096)
- mechlorethamine exposure (Q21513721): pseudomembrane (Q1495301): exudate (Q1139400)
- HN3 exposure (Q21514015): dryness (Q1513116): hallo (Q12835706)
- HN3 exposure (Q21514015): pseudomembrane (Q1495301): exudate (Q1139400)
- 3-quinuclidinyl benzilate exposure (Q21515284): sedation (Q574801): medical procedure (Q796194)
- 3-quinuclidinyl benzilate exposure (Q21515284): xeroderma (Q1929023): dryness (Q5309747)
- ricin exposure (Q21515358): death (Q4): end (Q12769393), concept (Q151885), property (Q937228), occurrence (Q1190554)
- sarin exposure (Q21733383): feeling (Q205555): perception (Q160402), emotional process (Q4531715)
- soman exposure (Q21738185): feeling (Q205555): perception (Q160402), emotional process (Q4531715)
- tabun exposure (Q21751013): feeling (Q205555): perception (Q160402), emotional process (Q4531715)
- VX exposure (Q21751044): feeling (Q205555): perception (Q160402), emotional process (Q4531715)
- tetrodotoxin poisoning (Q21862830): feeling (Q205555): perception (Q160402), emotional process (Q4531715)
- sulfur mustard exposure (Q21973551): urination (Q105726): biological process (Q2996394), excretion (Q185557), renal system process (Q14863382)
- alternative psychosis (Q25377826): Forced normalization (Q5467536): electroencephalography (Q179965)
- NGLY1-deficiency (Q28024539): electroencephalography abnormalities (Q29019794): medical finding (Q639907), abnormal medical finding (Q66650077)
- NGLY1-deficiency (Q28024539): elevated transaminases (Q2448873): medical finding (Q639907), liver enzyme changes (Q21117406)
- NGLY1-deficiency (Q28024539): abnormal brain imaging (Q29019857): medical finding (Q639907), abnormal medical finding (Q66650077), neuroimaging (Q551875)
- NGLY1-deficiency (Q28024539): functional motor deficit (Q29643060): medical finding (Q639907), motor dysfunction (Q21862894)
- NGLY1-deficiency (Q28024539): Multifocal epileptiform discharges (Q29643234): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): Abnormal metabolic brain imaging by MRS (Q29643776): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): Elevated brain choline level by MRS (Q29643793): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): High myoinositol in brain by MRS (Q30151297):
- NGLY1-deficiency (Q28024539): Decreased CSF total protein (Q30151275): medical finding (Q639907), abnormally low value (Q54928607)
- NGLY1-deficiency (Q28024539): Decreased CSF albumin (Q30150991): medical finding (Q639907), abnormally low value (Q54928607)
- NGLY1-deficiency (Q28024539): Decreased CSF/serum albumin ratio (Q30150985): medical finding (Q639907), abnormally low value (Q54928607)
- NGLY1-deficiency (Q28024539): Decreased CSF biopterin level (Q29643842): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): Mixed demyelinating and axonal polyneuropathy (Q30150966): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): Abnormal auditory evoked potentials (Q29019841): medical finding (Q639907), abnormal medical finding (Q66650077), auditory evoked potentials (Q6514933)
- NGLY1-deficiency (Q28024539): Decreased resting energy expenditure (Q29647375): clinical finding (Q28807560)
- NGLY1-deficiency (Q28024539): Reduced factor XI activity (Q30150680): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): Reduced factor IX activity (Q30150765): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): impaired daily living skills (Q56565019): medical finding (Q639907), disability (Q12131)
- NGLY1-deficiency (Q28024539): Reduced brain N-acetyl aspartate level by MRS (Q56565032): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): Reduced brain glutamine level by MRS (Q56565037): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): Reduced brain glutamate level by MRS (Q56565041): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): Reduced brain gamma-aminobutyric acid level by MRS (Q56565048): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): abnormal sudomotor regulation (Q56565058): medical finding (Q639907)
- NGLY1-deficiency (Q28024539): sucking reflex (Q2227392): medical finding (Q639907), primitive reflex (Q1472071)
- Q29376551: bark (Q38681): screaming (Q1932016)
- gaming disorder (Q49000071): depression (Q190429): geologic term (Q77330535), landform (Q271669)
- gaming disorder (Q49000071): social isolation (Q1778765): social phenomenon (Q602884), solitude (Q6010868), risk factor (Q1475848), human behavior (Q3769299)
- combined malonic and methylmalonic acidemia (Q55784284): Memory Problems (Q57915356): scholarly article (Q13442814)
- California encephalitis (Q60250812): confusion of consciousness (Q65202123):
- Head-Go-Boom-Boom-Itis (Q87751785): regression (Q1139051): defence mechanism (Q2866472)
- Head-Go-Boom-Boom-Itis (Q87751785): immaturity (Q63083485):
- chrono-impairment disorder (Q107214568): teleportation (Q11032077): superpower (Q1047698), fictional technology (Q1055307), fictional mode of transport (Q6619802), teleportation (Q204043)
- chrono-impairment disorder (Q107214568): time travel in fiction (Q253732): literary element (Q6647660), fictional entity (Q14897293)
- The Sickness (Q111036024): fatigue (Q15729017): physiological phenomenon (Q66615932), mental state (Q54989186), physiological condition (Q7189713)
- Lipaemia retinalis (Q111681631): colorlessness (Q11567495): physical property (Q4373292), absence (Q19829125), condition (Q813912), quality (Q1207505)
- Hemoglobin M disease (Q112672967): Hemoglobin M (Q76829973): abnormal hemoglobins (Q77836916)
- feline obesity (Q116167729): sedentism (Q1141745): lifestyle (Q32090)
- Deep Root Disease (Q116310153): transformation (Q65757353): type of process (Q116505632), superhuman quality (Q29604895), change (Q1150070), process (Q3249551)
- Deep Root Disease (Q116310153): growth (Q1342838): biological process (Q2996394), biological process (Q2996394), process (Q3249551), expansion (Q3733056), body size change (Q115305738)
Types statistics edit
"Type physiological condition (Q7189713), fictional medical condition (Q18596079)" violations edit
Violations count: 7
- veterinary medicine (Q170201): medical specialty (Q930752), academic discipline (Q11862829), academic major (Q4671286), industry (Q268592), medicine (Q11190), animal care (Q21012419), veterinary science (Q110245063)
- Q2349531: immunization (Q1415366)
- Osteochondritis dissecans (Q5071123): Wikimedia duplicated page (Q17362920), class of disease (Q112193867)
- abrin exposure (Q21281647): biological hazard (Q864360)
- adamsite exposure (Q21281859): chemical hazard (Q21167512)
- sulfur mustard exposure (Q21973551): chemical hazard (Q21167512)
- Lights Out (Q114772062): level of the Backrooms (Q114772035)
Types statistics edit
"Scope" violations edit
Violations count: 0
"Entity types" violations edit
Violations count: 0